Podcast Index
Podcasts
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Todo
Noticias
Política
Música
Deportes
Tecnología
Comedia
Arte
Negocios
Educación
Ficción
Gobierno
Salud & fitness
Historia
Niños & familia
Ocio
Religión & espiritualidad
Ciencia
Sociedad & cultura
Crimen real
TV & cine
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Somewhere in the Skies
SpectreVision Radio
Arkansas Row Crops Radio
University of Arkansas System Division of Agriculture
Public Health Out Loud
Dr. Philip Chan, Rhode Island Department of Health
Run for Your Lives Podcast
Pake & Daphne of Podcastica
The Beljanski Cancer Talk Show
The Beljanski Foundation
Gorilla Whale: A Godzilla Watch-Along Podcast
Digital Kaiju Studios
Heliox: Where Evidence Meets Empathy 🇨🇦
by SC Zoomers
The Wild Idea
Wild Idea Media
Viced Rhino: The Podcast
Viced Rhino
The Arora #CanPassWillPass Podcast
Dr Aman Arora
geister - der philosophie-podcast
Christian Eichler
Radiolab
WNYC Studios
The Future of Everything
Stanford Engineering
AgTech Digest
AgTech Media Group
Animal Posse
Unwanted Feline Organization
CURE SYNGAP1 PODCAST aka SYNGAP10
Syngap Research Fund, 501(c)(3)
La Terre au carré
France Inter
e-girl hyperborea
the master
SpaceTime with Stuart Gary
Stuart Gary
La Science CQFD
France Culture
La Science, CQFD
France Culture
Farming Today
BBC Radio 4
Sternengeschichten
Florian Freistetter
StarTalk Radio
Neil deGrasse Tyson
Stanford Psychology Podcast
Stanford Psychology
Pharma and BioTech Daily
Pharma and BioTech News
Digimasters Shorts
Adam Nagus, Carly Wilson
Bigfoot Crossroads
Matt Knapp
This Week in Science – The Kickass Science Podcast
Dr. Kirsten Sanford Science Media
Snake Talk
Dr. Chris Jenkins
La Mano Peluda
Radio Fórmula
VE A TERAPIA
Nathalia Molina | Genuina Media
PBS Space Time
PBS
Environment Daily
Ground Report
Relatos 3roticos En Español ORIGINAL
Eric
El colegio invisible
OndaCero
Ciencia
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will leverage its early-stage drug discovery platform to advance targets sele...
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timelines by six to 12 months as the US looks to reclaim its footing in glob...
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion
In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding a suite of clinical-stage immunology assets to its portfolio, Insilico Medicine enters an AI-po...
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
In today's Pharmaceutical Executive Daily, an FDA advisory committee votes unanimously in favor of the benefit-risk profile of Moderna's investigational mRNA-1010 seasonal influenza vaccine across both younger and older ...
Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive
In today's Pharmaceutical Executive Daily, Biogen announces its second acquisition of 2026, a deal worth up to $1 billion for private immunology biotech RayThera, FDA approves Utebzi as the first and only oral carbapenem...
Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs
In today's Pharmaceutical Executive Daily, FDA staff release briefing documents flagging evidence gaps in Moderna's mRNA flu vaccine, a pharma roundup covers Merck's $510 million collaboration with Protillion Biosciences...
Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm
In today's Pharmaceutical Executive Daily, Elicio Therapeutics shares tumble after its Phase II Amplifgy-7P trial of KRAS-targeting immunotherapy ELI-002 7P misses its primary endpoint in adjuvant pancreatic cancer, FDA ...
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pharma regulatory roundup covers two significant FDA approvals, and Pharma...
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the cardiovascular biotech at approximately $1.3 billion, Pharmaceutical Executive speaks with Rick Winningham on bui...
Pharmaceutical Executive Daily: China's Latest Policy Guidance
In today's Pharmaceutical Executive Daily, Bruce Liu examines China's latest policy guidance establishing premium pricing and priority reimbursement access for truly innovative drugs, Parabilis Medicines surges more than...
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
In today's Pharmaceutical Executive Daily, Parabilis Medicines prices a record-breaking $670 million IPO, Swedish biotech AlzeCure Pharma enters a collaboration and out-licensing agreement with Eli Lilly for its Alzheime...
The Ron Lanton Report: From Innovation to Infrastructure
In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing novel ideas to funding organizations that can scale, survive regulatory...
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
In today's Pharmaceutical Executive Daily, a pharma funding roundup covers two RNA-focused biotechs that secured fresh capital, GSK announces a $10.6 billion agreement to acquire Nuvalent in its largest deal in over a de...
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
In today's Pharmaceutical Executive Daily, Roche and Nurix Therapeutics announce a global collaboration, a pharma M&A roundup covers three deals announced today, and Pharmaceutical Executive contributors examine how an e...
Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case
In today's Pharmaceutical Executive Daily, the Supreme Court unanimously rules in favor of Hikma Pharmaceuticals in its patent dispute with Amarin over Vascepa, Pfizer licenses Chai Discovery's generative AI platform, an...
Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly escalates its 340B enforcement standoff by notifying covered entities of a five-business-day window to submit required claims data or lose access to 340B pricing, Alny...
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
In this episode of Pricing & Policy with Model N, Jesse Mendelsohn, senior vice president at Model N, joins host Mike Christel to offer a candid, expert-driven look at the pharmacy benefit manager (PBM) landscape, includ...
Pharmaceutical Executive Daily: New FDA Draft Guidance Targets Gene Therapy Submission Burden
In today's Pharmaceutical Executive Daily, Cam Olig of Prescryptive Health touches on the results of a new market access survey, Eli Lilly and Ascidian Therapeutics announce a global research collaboration worth up to $1...
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
In today's Pharmaceutical Executive Daily, FDA has accepted a new drug application for giredestrant under priority review, FDA also issues a complete response letter for Cingulate's CTx-1301, and Dan Troy, former FDA Chi...